14d
Vir Biotechnology Inc (VIR) showcases progress in oncology and infectious disease programs while managing financial hurdles ...
Q4 2024 Earnings Call Transcript February 26, 2025 Vir Biotechnology, Inc. beats earnings expectations. Reported EPS is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback